1. Steatosis influences hepatocytes proliferative potential in chronic hepatitis C patients
- Author
-
Maciej Horyniecki, Waldemar Halota, Andrzej Gabriel, Brygida Adamek, Kamil Tabor, Grzegorz Banasik, and Michał Kukla
- Subjects
nonalcoholic fatty liver disease ,medicine.medical_specialty ,lcsh:Medicine ,Inflammation ,Disease ,Gastroenterology ,Pathology and Forensic Medicine ,Ballooning degeneration ,Chronic hepatitis ,Non-alcoholic Fatty Liver Disease ,Internal medicine ,Nonalcoholic fatty liver disease ,steatosis ,chronic hepatitis C ,PCNA ,Humans ,Medicine ,Cell Proliferation ,biology ,business.industry ,lcsh:R ,General Medicine ,Hepatitis C, Chronic ,medicine.disease ,Proliferating cell nuclear antigen ,hepatocyte ballooning ,medicine.anatomical_structure ,Liver ,Hepatocyte ,Hepatocytes ,biology.protein ,medicine.symptom ,Steatosis ,business - Abstract
The study evaluates the influence of steatosis on hepatocytes proliferative potential, reflected by proliferating cell nuclear antigen (PCNA) expression in chronic hepatitis C (CHC) patients both in steatotic and non-steatotic areas of lobules. The liver histology was evaluated according to Kleiner’s score. Nonalcoholic steatohepatitis (NASH) was also defined as the presence of lobular inflammation, hepatocyte ballooning and steatosis. Expression of PCNA was significantly in patients with definite NASH compared to those with simple steatosis, but not to those with borderline NASH. Advanced steatosis negatively influenced PCNA expression. NASH not only affects PCNA expression in staetotic, but also in non-steatotic lobule areas. Expression of PCNA could be an independent indicator of changes in hepatocyte metabolism in CHC patients. High NAS values and low PCNA expression may be a negative prognostic factor in predicting the further course of the disease.
- Published
- 2018
- Full Text
- View/download PDF